In a study investigating patients with chronic obstructive pulmonary disease (COPD), an inflammatory lung disease in which irreversible fibrotic changes occur in the airways, lower plasma prolidase activity was observed in COPD patients compared to the control group (p < 0.05) [26]. This evidence concerns the gene PEPD and chronic obstructive pulmonary disease.